Generic Semaglutide: Lower-Cost Semaglutide is Here!
BUY NOW
We Ship To The U.S. Only
10% Off On Your First Order
Click on the Copy Code button to copy your code.
No Expiry
Exclusive On Duty Free Meds Only
The costs of weight loss and type 2 diabetes medications like Mounjaro (tirzepatide) can be expensive for patients who do not have coverage. The high costs associated with these medications can be stressful for patients. This has been an increasing concern as Mounjaro has become one of the most popular off-label medications used for weight loss. This has caused an increase in demand and shortages across areas like Canada and the U.S.
It may be extra difficult for patients to get coverage for Mounjaro if they are not using their medication for type 2 diabetes treatment. Many insurance plans do not cover this medication for its off-label weight loss use. However, shortages of the medication have caused problems for type 2 diabetes patients as well. This article will cover the monthly out-of-pocket costs of the medication for patients who do not have insurance coverage and some additional ways that patients can save on their prescription. It will also cover the cost variations between pharmacies and what to do in the case of prescription fulfillment issues or shipment delays due to the shortages.
Note: This content is intended for informational use only and should not be taken in the place of professional medical advice.
10% Off On Your First Order
Click on the Copy Code button to copy your code.
No Expiry
Exclusive On Duty Free Meds Only
| Estimated Monthly Cost (USD) | |
| List Price | $1,079.77 |
| Retail Price | About $1,050-$1,200 |
| Price With Insurance | Sometimes $25 or less |
The manufacturer has set the list price of Mounjaro at $1,079.77 per month. However, how much patients will pay for this medication each month if they do not have insurance coverage may vary. The retail price of Mounjaro can range anywhere from about $1,050-$1,200 per month. The exact amount depends on the pharmacy from which the patient buys the medication and where the pharmacy is located.
Patients who are paying for Mounjaro out of pocket may spend over $12,000 (USD) for their medication each year. Those who do have insurance coverage may be able to pay as little as $25 per month or less. Different insurance plans may provide different amounts of coverage.
The cost of Mounjaro varies depending on where the patient lives and whether they have insurance coverage. Prices differ between the U.S and other countries. For example, prices start around closer to $560 USD in Canada for the same medication. This is mostly due to healthcare regulations and pharmacy pricing policies. Currency exchange rates may also impact how much the patient pays for the medication.
The cost of Mounjaro is influenced by a few different factors.
Shortages may also have an impact on the coverage patients receive. This is a common issue for medications like Ozempic and Mounjaro. There have been some reports of patients who previously had coverage for one of these medications suddenly losing that coverage as demand and prices for those medications increased. These medications are increasingly hard to get coverage for if they are not being used to treat type 2 diabetes.
Some experts estimate that only about 30% of commercially insured patients have coverage for obesity medications. These medications are also generally not covered by Medicare or Medicaid when used for this purpose. A cheaper generic form of the medication may be a better option for these patients.
Insurance plans can differ and each patient’s coverage level may vary. Insurance holders may be able to use the Mounjaro Savings Card. This card is for people who have commercial insurance and no government insurance coverage. This card allows some patients to fill their prescriptions for as little as $25 (USD) per month. Each prescription fill provides four pens – which typically covers a 28-day supply. Patients can use this card to save no more than $6,019 each year.
Patients who do not have any insurance coverage generally are responsible for paying the full retail price of Mounjaro out of pocket. However, some of these patients may still be eligible for other assistance programs to help lower that cost. The Lilly Cares Foundation Patient Assistance Program can help eligible patients pay for some of these manufacturers’ medications in the U.S. Lilly Cares Foundation still does not list Mounjaro as of 2026. Some other patient assistance programs may still be available.
Patients who are paying for their Mounjaro out of pocket have a few different options to try to save some money.
There is one other option that patients without coverage may have. That is ordering their prescription medication through a Canadian prescription fulfillment service like Duty Free Meds. We offer more affordable prices and mounjaro coupons for the exact same name-brand medications that are sold in the U.S. These medications can be ordered online with a prescription and shipped discreetly to the patient’s home.
| Medication Name | Medication Type | Price in USD (Without Insurance) |
| Mounjaro (Tirzepatide) |
| $1,050-$1,200 per month |
| Ozempic (Semaglutide) |
| $995+ per month |
| Trulicity (Dulaglutide) |
| $863+ per month |
| Rybelsus (Semaglutide) |
| $978+ per month |
| Zepbound (Tirzepatide) |
| $500+ (vial form) – $1,000+ (pen form) per month |
Mounjaro is not a cheap expense without insurance coverage. Patients may have an easier time managing these expenses by comparing their options between different locations. They may also be able to save through assistance programs and savings cards. Some websites may also offer coupons and more affordable prices to those who are not eligible for any other form of coverage.
Get more affordable Canadian pricing and coupons on medications like Mounjaro today at Duty Free Meds.
The monthly retail cost of Mounjaro typically ranges from $1,050-$1,200 (USD) for those who do not have insurance coverage. The exact price may vary depending on the pharmacy the patient is buying from and the location.
Patients covered by commercial insurance could qualify for the Mounjaro Savings Card. This can bring the costs down to as low as $25 per month. Those without insurance may still find savings through prescription discount platforms like GoodRx and SingleCare. Patients can also look into patient assistance programs or explore Canadian prescription services for more affordable options.
Other GLP-1 receptor agonists – such as Ozempic or Trulicity – may have similar benefits and come at slightly lower prices. Patients using Mounjaro specifically for weight loss might also consider Zepbound. This medication is approved for weight management and may offer different coverage or pricing options.
Both Mounjaro and Ozempic are effective treatments for type 2 diabetes and are used off-label for weight loss. Mounjaro can cause more significant weight loss in some patients than others due to its dual GIP and GLP-1 receptor action. However, the better option will depend on the specific patient the medication is being used to treat and their medical history.
Most of the side effects of Mounjaro are gastrointestinal and resolve as the patient’s body gets used to the medication. Some patients may also experience side effects like dizziness or injection site reactions. Serious side effects – which are rare – include pancreatitis and thyroid cancer. It also includes kidney problems, hypoglycemia, or gallbladder issues.
This medication is usually covered under Medicare Part D as long as it is being used for the purpose of treating type 2 diabetes.
Shortages can vary from anywhere to a few weeks to years. Studies show that injectable medications like Mounjaro usually have a shortage for an average of 4.6 years. Oral medication shortages have an average of 1.6 years per shortage and topical medications have an average of 2.2 years per shortage.
Table of Contents
ToggleDisclaimer: The information presented here is intended solely for educational purposes and should not be interpreted as medical advice, a diagnosis, or specific treatment recommendations. It does not imply endorsement of any particular medication or therapy. Health conditions and treatment responses can differ significantly between individuals; thus, this information is not a guarantee of safety, suitability, or effectiveness for anyone in particular. Always seek the guidance of a healthcare professional for personalized medical advice and consult them before making any health or treatment decisions.